TOVX
Theriva Biologics, Inc.
+0.01 (+3.83%)0.24USD274K成交股數11.0M市值0.2本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | 300K | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.3M | 355K | 2.6M | 2.0M | 3.0M | 2.9M | 2.7M | 3.0M | 3.5M | 4.0M | 3.1M | 3.0M |
| 銷售管理費用 | 2.0M | 2.1M | 1.9M | 11.2M | 1.4M | 1.7M | 2.3M | 1.5M | 1.9M | 212K | 2.7M | 2.2M |
| 營業利益 | −3.3M-25% | −2.1M-54% | −4.4M-44% | −13.1M+55% | −4.4M-18% | −4.6M+9% | −7.9M+36% | −8.5M+64% | −5.4M | −4.2M | −5.8M | −5.2M |
| 營業利益率 | – | -709.0% | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.2M-26% | −2.0M-54% | −4.4M-44% | −13.1M+57% | −4.3M-16% | −4.4M+35% | −7.7M+52% | −8.3M+86% | −5.2M | −3.3M | −5.1M | −4.5M |
| 淨利率 | – | -681.3% | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.07-95% | -0.05-101% | -0.45-93% | -1.93-82% | -1.55-79% | 6.03-224% | -6.81+1903% | -10.72+3473% | -7.53 | -4.85 | -0.34 | -0.30 |
| 稀釋股數 | 45.9M | 41.1M | 9.7M | 6.8M | 2.8M | 1.3M | 1.1M | 776K | 686K | 682K | 15.2M | 15.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 11.3M | 14.4M | 7.5M | 12.1M | 10.0M | 11.6M | 16.4M | 16.6M | 18.3M | 31.2M | 34.2M | 36.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 34.9M | 38.2M | 30.8M | 35.8M | 32.2M | 35.4M | 40.1M | 42.4M | 48.7M | 61.5M | 65.4M | 67.9M |
| 有息負債 | – | – | – | – | – | 92K | – | – | – | 150K | 153K | 160K |
| 總負債 | 22.7M | 22.8M | 24.1M | 25.2M | 16.7M | 16.3M | 15.5M | 14.7M | 14.6M | 17.7M | 17.7M | 17.3M |
| 股東權益 | 12.2M | 15.4M | 6.7M | 10.6M | 15.5M | 19.1M | 24.6M | 25.9M | 31.4M | 41.2M | 45.0M | 47.9M |
| 負債比 | 65.0% | 59.7% | 78.1% | 70.4% | 51.8% | 46.1% | 38.6% | 34.8% | 30.0% | 28.7% | 27.0% | 25.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | 11.5M | – | – | – | 31.0M | 34.1M | 35.9M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.5M | – | – | −4.8M-3% | – | – | – | −4.9M | – | – | −5.6M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 8K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −5.6M |
| 折舊攤銷 | – | 24K | – | – | 26K | – | – | – | 39K | – | – | 32K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −23.7M | –% | -2.08 | −16.7M |
| FY2024 | – | – | −25.7M | –% | -19.03 | −16.9M |
| FY2023 | – | – | −18.3M | –% | -28.48 | −19.2M |
| FY2022 | – | – | −19.7M | –% | -1.31 | −19.2M |
| FY2021 | – | – | −14.3M | –% | -1.90 | −12.9M |
| FY2020 | – | – | −10.0M | –% | -0.66 | −12.2M |
| FY2019 | – | – | −15.3M | –% | -0.98 | −13.9M |
| FY2018 | – | – | −13.4M | –% | -4.06 | −17.3M |